Skip to main content
SpringerLink
Log in

Pharmacological Interventions

  • Chapter
  • First Online:
Handbook of Cognitive Behavioral Therapy for Pediatric Medical Conditions

Part of the book series: Autism and Child Psychopathology Series ((ACPS))

  • 1789 Accesses

Abstract

A robust evidence base exists for the use of CBT to shape behavior and treat various disorders in youth. There are also strong empirical data to support the use of pharmacological agents in children and adolescents to accomplish behavioral change and for the management of various conditions, including anxiety, depression, posttraumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), bipolar disorder, psychosis, tics, insomnia, and attention-deficit/hyperactivity disorder (ADHD). Numerous studies have found the combination of CBT and medication to be most effective for treating many of these illnesses. In this chapter, we will discuss general principles and specific strategies for pharmacological intervention and focus on disorders where the combined use of medication and CBT has been well studied and is relevant to the treatment of children and adolescents coping with pediatric medical conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Achenbach, T. M. (1991a). Manual for the child behavior checklist/ 4–18 and 1991 profile. Burlington, VT: University of Vermont, Department of Psychiatry.

    Google Scholar 

  • Achenbach, T. M. (1991b). Manual for the youth self-report and 1991 profile. Burlington, VT: University of Vermont, Department of Psychiatry.

    Google Scholar 

  • Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4, 561–571.

    Article  Google Scholar 

  • Berard, R., Fong, R., Carpenter, D. J., Thomason, C., & Wilkinson, C. (2006). An international, multicenter, placebo-controlled trial of paroxetine in adolescents with major depressive disorder. Journal of Child and Adolescent Psychopharmacology, 16(1–2), 59–75.

    Article  Google Scholar 

  • Birmaher, B., Brent, D. A., Chiappetta, L., Bridge, J., Monga, S., & Baugher, M. (1999). Psychometric properties of the screen for child anxiety related emotional disorders (SCARED): A replication study. Journal of the American Academy of Child and Adolescent Psychiatry, 38(10), 1230–1236.

    Article  Google Scholar 

  • Birmaher, B., Axelson, D. A., Monk, K., Kalas, C., Clark, D. B., Ehmann, M., et al. (2003). Fluoxetine for the treatment of childhood anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 42(4), 415–423.

    Article  Google Scholar 

  • Bridge, J. A., Iyengar, S., Salary, C. B., Barbe, R. P., Birmaher, B., Pincus, H. A., et al. (2007). Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: A meta-analysis of randomized controlled trials. Journal of the American Medical Association, 297(15), 1683–1696.

    Article  Google Scholar 

  • Brooks, R. K., & Strawn, J. R. (2014). Psychological and pharmacologic treatment of youth with posttraumatic stress disorder-an evidence-based review. Child and Adolescent Psychiatric Clinics of North America, 23, 399–411.

    Article  Google Scholar 

  • Brosbe, M. S., Faust, J., & Gold, S. N. (2013). Complex traumatic stress in the pediatric medical setting. Journal of Trauma & Dissociation, 14, 97–112.

    Article  Google Scholar 

  • Brown, L. K., Kennard, B. D., Emslie, G. J., Mayes, T. L., Whiteley, L. B., Bethel, J., et al. (2016). Effective treatment of depressive disorders in medical clinics for adolescents and young adults living with HIV: A controlled trial. Journal of Acquired Immune Deficiency Syndromes, 71(1), 38–46.

    Article  Google Scholar 

  • Bursch, B., & Forgey, M. (2013). Psychopharmacology for medically ill adolescents. Current Psychiatry Reports, 15(10), 395.

    Article  Google Scholar 

  • Cipriani, A., Zhou, X., Del Giovane, C., Hetrick, S. E., Qin, B., Whittington, C., et al. (2016). Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: A network meta-analysis. Lancet, 388, 881–890.

    Article  Google Scholar 

  • Cohen, J. A., Mannarino, A. P., Perel, J. M., & Staron, V. (2007). A pilot randomized controlled trial of combined trauma-focused CBT and sertraline for childhood PTSD symptoms. Journal of the American Academy of Child and Adolescent Psychiatry, 46(7), 811–819.

    Article  Google Scholar 

  • Connor, D. F., Grasso, D. J., Slivinsky, M. D., Pearson, G. S., & Banga, A. (2013). An open-label study of guanfacine extended release for traumatic stress related symptoms in children and adolescents. Journal of Child and Adolescent Psychopharmacology, 23(4), 244–251.

    Article  Google Scholar 

  • Creswell, C., & Waite, P. (2016). Recent developments in the treatment of anxiety disorders in children and adolescents. Evidence-Based Mental Health, 19(3), 65–68.

    Article  Google Scholar 

  • Emslie, G. J., Wagner, K. D., Kutcher, S., Krulewicz, S., Fong, R., Carpenter, D. J., et al. (2006). Paroxetine treatment in children and adolescents with major depressive disorder: A randomized, multicenter, double-blind, placebo-controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 45(6), 709–719.

    Article  Google Scholar 

  • Emslie, G. J., Ventura, D., Korotzer, A., Tourkodimitris, S., et al. (2009). Escitalopram in the treatment of adolescent depression: A randomized placebo-controlled multisite trial. Journal of the American Academy of Child and Adolescent Psychiatry, 48(7), 721–729.

    Article  Google Scholar 

  • Famularo, R., Kinscherff, R., & Fenton, T. (1988). Propranolol treatment for childhood posttraumatic stress disorder, acute type. A pilot study. The American Journal of Diseases of Children, 142(11), 1244–1247.

    Article  Google Scholar 

  • Foa, E. B., Johnson, K. M., Feeny, N. C., & Treadwell, K. R. H. (2001). The child PTSD symptom scale: A preliminary examination of its psychometric properties. Journal of Clinical Child Psychology, 30(3), 376–384.

    Article  Google Scholar 

  • Gibbons, R. D., Brown, C. H., Hur, K., Marcus, S. M., Bhaumik, D. K., Erkens, J. A., et al. (2007). Early evidence on the effects of regulators’ suicidality warnings on SSRI prescriptions and suicide in children and adolescents. American Journal of Psychiatry, 164(9), 1356–1363.

    Article  Google Scholar 

  • Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23, 56–62.

    Article  Google Scholar 

  • Hammad, T. A., Laughren, T., & Racoosin, J. (2006). Suicidality in pediatric patients treated with antidepressant drugs. Archives of General Psychiatry, 63(3), 332–339.

    Article  Google Scholar 

  • Harmon, R. J., & Riggs, P. D. (1996). Clonidine for posttraumatic stress disorder in preschool children. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1247–1249.

    Article  Google Scholar 

  • Horrigan, J. P., & Barnhill, L. J. (1999). Risperidone and PTSD in boys. The Journal of Neuropsychiatry and Clinical Neurosciences, 11, 126–127.

    Google Scholar 

  • Ipser, J. C., Stein, D. J., Hawkridge, S., & Hoppe, L. (2010). Pharmacotherapy for anxiety disorders in children and adolescents (review). The Cochrane Collaboration, 6, 1–72.

    Google Scholar 

  • Keeshin, B. R., & Strawn, J. R. (2014). Psychological and pharmacologic treatment of youth with posttraumatic stress disorder: an evidence-based review. Child and Adolescent Psychiatric Clinics of North America, 23(2), 399–411.

    Google Scholar 

  • Keller, M. B., Ryan, N. D., Strober, M., Klein, R. G., Kutcher, S. P., Birmaher, B., et al. (2001). Efficacy of paroxetine in the treatment of adolescent major depression: A randomized, controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 40(7), 762–772.

    Article  Google Scholar 

  • Kolves, K., & De Leo, D. (2016). Adolescent suicide rates between 1990 and 2009: Analysis of age group 15-19 years worldwide. Journal of Adolescent Health, 58, 69–77.

    Article  Google Scholar 

  • Kovacs, M. (1985). The children’s depression inventory (CDI). Psychopharmacology Bulletin, 21(4), 995–998.

    Google Scholar 

  • Locher, C., Koechlin, H., Zion, S. R., Werner, C., Pine, D. S., Kirsch, I., et al. (2017). Efficacy and safety of serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and placebo for common psychiatric disorders among children and adolescents: A systematic review and meta-analysis. JAMA Psychiatry, 74(10), 1011–1020.

    Article  Google Scholar 

  • Looff, D., Grimley, P., Kuller, F., Martin, A., & Shonfield, L. (1995). Carbamazepine for PTSD. Journal of the American Academy of Child and Adolescent Psychiatry, 34(6), 703–704.

    Article  Google Scholar 

  • March, J. S., & Vitiello, B. (2009). Clinical messages from the treatment for adolescents with depression study (TADS). American Journal of Psychiatry, 166(10), 1118–1123.

    Article  Google Scholar 

  • March, J. S., Parker, J. D. A., Sullivan, K., Stallings, P., & Conners, C. K. (1997). The multidimensional anxiety scale for children (MASC): Factor structure, reliability, and validity. Journal of the American Academy of Child and Adolescent Psychiatry, 36(4), 554–565.

    Article  Google Scholar 

  • Meighen, K. G., Hines, L. A., & Lagges, A. M. (2007). Risperidone treatment of preschool children with thermal burns and acute stress disorder. Journal of Child and Adolescent Psychopharmacology, 17(2), 223–232.

    Article  Google Scholar 

  • Merikangas, K. R., He, J. P., Burstein, M., Swanson, S. A., Avenevoli, S., Cui, L., et al. (2010). Lifetime prevalence of mental disorders in us adolescents: Results from the national comorbidity survey replication—Adolescent supplement (NCS-A). Journal of the American Academy of Child and Adolescent Psychiatry, 49, 980–989.

    Article  Google Scholar 

  • Nugent, N. R. (2007). The efficacy of early propranolol administration at preventing/reducing PTSD symptoms in child trauma victims: Pilot. Dissertation, Kent State University.

    Google Scholar 

  • Park, E. M., & Rosenstein, D. L. (2015). Depression in adolescents and young adults with cancer. Dialogues in Clinical Neuroscience, 17(2), 171–180.

    Article  Google Scholar 

  • Perry, B. D. (1994). Neurobiological sequelae of childhood trauma: PTSD in children. In M. M. Murburg (Ed.), Catecholamine function in posttraumatic stress disorder: Emerging concepts (pp. 233–255). Washington, DC: American Psychiatric Press.

    Google Scholar 

  • Piacentini, J., Bennett, S., Compton, S. N., Kendall, P. C., Birmaher, B., Albano, A. M., et al. (2014). 24- and 36-week outcomes for the child/adolescent anxiety multimodal study (CAMS). Journal of the American Academy of Child and Adolescent Psychiatry, 53(3), 297–310.

    Article  Google Scholar 

  • Robb, A. S., Cueva, J. E., Sporn, J., Yang, R., & Vanderburg, D. G. (2010). Sertraline treatment of children and adolescents with posttraumatic stress disorder: A double-blind, placebo-controlled trial. Journal of Child and Adolescent Psychopharmacology, 20(6), 463–471.

    Article  Google Scholar 

  • Rynn, M. A., Riddle, M. A., Yeung, P. P., & Kunz, N. R. (2007). Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: Two placebo-controlled trials. American Journal of Psychiatry, 164(2), 290–300.

    Article  Google Scholar 

  • Rzucidlo, S. E., & Campbell, M. (2009). Beyond the physical injuries: Child and parent coping with medical traumatic stress after pediatric trauma. Journal of Trauma Nursing, 16(3), 130–135.

    Article  Google Scholar 

  • Sakolsky, D., & Birmaher, B. (2012). Developmentally informed pharmacotherapy for child and adolescent depressive disorders. Psychiatric Clinics of North America, 21, 313–325.

    Google Scholar 

  • Seedat, S., Lockhat, R., Kaminer, D., Zungu-Dirwayi, N., & Stein, D. J. (2001). An open trial of citalopram in adolescents with post-traumatic stress disorder. International Clinical Psychopharmacology, 16(1), 21–25.

    Article  Google Scholar 

  • Seedat, S., Stein, D. J., Ziervogel, C., Middleton, T., Kaminer, D., Emsley, R. A., et al. (2002). Comparison of response to a selective serotonin reuptake inhibitor in children, adolescents, and adults with posttraumatic stress disorder. Journal of Child and Adolescent Psychopharmacology, 12(1), 37–46.

    Article  Google Scholar 

  • Shatkin, J. P. (2015). Child & adolescent mental health-a practical, all-in-one guide (2nd ed.). New York: W.W. Norton.

    Google Scholar 

  • Stathis, S., Martin, G., & McKenna, J. G. (2005). A preliminary case series on the use of quetiapine for posttraumatic stress disorder in juveniles within a youth detention center. Journal of Clinical Psychopharmacology, 25(6), 539–544.

    Article  Google Scholar 

  • Steinberg, A. M., Brymer, M., Decker, K., & Pynoos, R. S. (2004). The University of California at Los Angeles post-traumatic stress disorder reaction index. Current Psychiatry Reports, 6, 96–100.

    Article  Google Scholar 

  • Steiner, H., Saxena, K. S., Carrion, V., Khanzode, L. A., Silverman, M., & Chang, K. (2007). Divalproex sodium for the treatment of PTSD and conduct disordered youth: A pilot randomized controlled clinical trial. Child Psychiatry and Human Development, 38(3), 183–193.

    Article  Google Scholar 

  • Strawn, J. R., Prakash, A., Zhang, Q., Pangallo, B. A., Stroud, C. E., Cai, N., et al. (2015a). A randomized, placebo-controlled study of duloxetine for the treatment of children and adolescents with generalized anxiety disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 54(4), 283–293.

    Article  Google Scholar 

  • Strawn, J. R., Welge, J. A., Wehry, A. M., Keeshin, B. R., & Rynn, M. A. (2015b). Efficacy and tolerability of antidepressants in pediatric anxiety disorders: A systematic review and meta-analysis. Depression and Anxiety, 32(3), 149–157.

    Article  Google Scholar 

  • Strawn, J. R., Mills, J. A., Sauley, B. A., & Welge, J. A. (2018). The impact of antidepressant dose and class on treatment response in pediatric anxiety disorders: A meta-analysis. Journal of the American Academy of Child and Adolescent Psychiatry, 57(4), 235–244.

    Article  Google Scholar 

  • The Research Unit on Pediatric Psychopharmacology Anxiety Study Group. (2001). Fluvoxamine for the treatment of anxiety disorders in children and adolescents. New England Journal of Medicine, 344(17), 1279–1285.

    Article  Google Scholar 

  • Uthman, O. A., & Abdulmalik, J. (2010). Comparative efficacy and acceptability of pharmacotherapeutic agents for anxiety disorders in children and adolescents: A mixed treatment comparison meta-analysis. Current Medical Research and Opinion, 26(1), 53–59.

    Article  Google Scholar 

  • Varigonda, A. L., Jakubovski, E., Taylor, M. J., Freemantle, N., Coughlin, C., & Bloch, M. H. (2015). Systematic review and meta-analysis: Early treatment responses of selective serotonin reuptake inhibitors in pediatric major depressive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 54(7), 557–564.

    Article  Google Scholar 

  • von Knorring, A. L., Olsson, G. I., Thomsen, P. H., Lemming, O. M., & Hulten, A. (2006). A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder. Journal of Clinical Psychopharmacology, 26(3), 311–315.

    Article  Google Scholar 

  • Wagner, K. D., Ambrosini, P., Rynn, M., Wohlberg, C., Yang, R., Greenbaum, M. S., et al. (2003). Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: Two randomized controlled trials. Journal of the American Medical Association, 290(8), 1033–1041.

    Article  Google Scholar 

  • Wagner, K. D., Robb, A. S., Findling, R. L., Jin, J., Gutierrez, M. M., & Heydorn, W. E. (2004). A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. American Journal of Psychiatry, 161(6), 1079–1083.

    Article  Google Scholar 

  • Wagner, K. D., Jonas, J., Findling, R. L., Ventura, D., & Saikali, K. (2006). A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression. Journal of the American Academy of Child and Adolescent Psychiatry, 45(3), 280–288.

    Article  Google Scholar 

  • Walkup, J. T., Albano, A. M., Piacentini, J., Birmaher, B., Compton, S. N., Sherrill, J. T., et al. (2008). Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. New England Journal of Medicine, 359(26), 2753–2766.

    Article  Google Scholar 

  • Xu, Y., Bai, S. J., Lan, X. H., Qin, B., Huang, T., & Xie, P. (2016). Randomized controlled trials of serotonin-norepinephrine reuptake inhibitor in treating major depressive disorder in children and adolescents: A meta-analysis of efficacy and acceptability. Brazilian Journal of Medical and Biological Research, 49(6), 1–8.

    Article  Google Scholar 

  • Zohar, J., Juven-Wetzler, A., Sonnino, R., Cwikel-Hamzany, S., Balaban, E., & Cohen, H. (2011). New insights into secondary prevention in post-traumatic stress disorder. Dialogues in Clinical Neuroscience, 13(3), 301–309.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Child and Adolescent Psychiatry, Hassenfeld Children’s Hospital at NYU Langone, Child Study Center, New York, NY, USA

    Rahil R. Jummani

  2. Department of Child and Adolescent Psychiatry, Child and Adolescent Mental Health Studies (CAMS), NYU College of Arts and Science and Hassenfeld Children’s Hospital at NYU Langone, Child Study Center, New York, NY, USA

    Jess P. Shatkin

Authors
  1. Rahil R. Jummani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jess P. Shatkin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rahil R. Jummani .

Editor information

Editors and Affiliations

  1. Child Emphasis Area, Palo Alto University, Palo Alto, CA, USA

    Robert D. Friedberg

  2. Division of Developmental and Behavioral Pediatrics, Stead Family Department of Pediatrics, University of Iowa Stead Family Children’s Hospital, Iowa City, IA, USA

    Jennifer K. Paternostro

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Jummani, R.R., Shatkin, J.P. (2019). Pharmacological Interventions. In: Friedberg, R.D., Paternostro, J.K. (eds) Handbook of Cognitive Behavioral Therapy for Pediatric Medical Conditions. Autism and Child Psychopathology Series. Springer, Cham. https://doi.org/10.1007/978-3-030-21683-2_11

Download citation

Publish with us

Policies and ethics

Search

Navigation